DERIVATIVES AND HEDGING ACTIVITIES (Tables)
|
9 Months Ended |
Mar. 31, 2021 |
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
|
Schedule of Derivative Instruments |
As of March 31, 2021, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:
| | | | | | | | | Interest Rate Derivative | Number of Instruments | Notional Amount | Interest Rate Swap | 4 | $230,000 |
As of March 31, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its foreign exchange risks:
| | | | | | | | | | | | Foreign Currency Derivative | Number of Instruments | Notional Sold | Notional Purchased | Cross-currency swap | 1 | €24,700 | $26,775 | | | | |
As of March 31, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:
| | | | | | | | | | | | Foreign Currency Derivative | Number of Instruments | Notional Sold | Notional Purchased | Cross-currency swap | 2 | €76,969 | $83,225 |
|
Derivative Financial Instruments and Classification on Consolidated Balance Sheets |
The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of March 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | | | Asset Derivatives | | Liability Derivatives | | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value | Derivatives designated as hedging instruments: | | | | | | | | Interest rate swaps | Prepaid expenses and other current assets | | $ | 9 | | | Accrued expenses and other current liabilities / Other noncurrent liabilities | | $ | 313 | | Cross-currency swaps | Prepaid expenses and other current assets | | 673 | | | Other noncurrent liabilities | | 10,518 | | | | | | | | | | Total derivatives designated as hedging instruments | | | $ | 682 | | | | | $ | 10,831 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of June 30, 2020:
| | | | | | | | | | | | | | | | | | | | | | | | | Asset Derivatives | | Liability Derivatives | | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value | Derivatives designated as hedging instruments: | | | | | | | | Interest rate swaps | Prepaid expenses and other current assets | | $ | — | | | Accrued expenses and other current liabilities / Other noncurrent liabilities | | $ | 856 | | Cross-currency swaps | Prepaid expenses and other current assets | | 746 | | | Other noncurrent liabilities | | 5,475 | | Foreign currency forward contracts | Prepaid expenses and other current assets | | 75 | | | Other noncurrent liabilities | | — | | Total derivatives designated as hedging instruments | | | $ | 821 | | | | | $ | 6,331 | | | | | | | | | | Derivatives not designated as hedging instruments: | | | | | | | | Foreign currency forward contracts | Prepaid expenses and other current assets | | 193 | | | Accrued expenses and other current liabilities | | 74 | | Total derivative instruments | | | $ | 1,014 | | | | | $ | 6,405 | |
|
Pre-Tax Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss |
The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the three months ended March 31, 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | | | | | Derivatives in Cash Flow Hedging Relationships | Amount of Gain (Loss) Recognized in OCI on Derivatives | Location of Gain (Loss) Reclassified from AOCL into Income | Amount of Gain (Loss) Reclassified from AOCL into Income | | Three Months Ended March 31, | | Three Months Ended March 31, | | 2021 | | 2020 | | 2021 | | 2020 | Interest rate swaps | $ | 217 | | | $ | — | | Interest and other financing expense, net | $ | (82) | | | $ | — | | Cross-currency swaps | 1,262 | | | — | | Interest and other financing expense, net / Other expense (income), net | 1,239 | | | — | | Foreign currency forward contracts | — | | | 134 | | Cost of sales | — | | | $ | — | | Total | $ | 1,479 | | | $ | 134 | | | $ | 1,157 | | | $ | — | |
The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the nine months ended March 31, 2021 and 2020: | | | | | | | | | | | | | | | | | | | | | | | | Derivatives in Cash Flow Hedging Relationships | Amount of Gain (Loss) Recognized in OCI on Derivatives | Location of Gain (Loss) Reclassified from AOCL into Income | Amount of Gain (Loss) Reclassified from AOCL into Income | | Nine Months Ended March 31, | | Nine Months Ended March 31, | | 2021 | | 2020 | | 2021 | | 2020 | Interest rate swaps | $ | 341 | | | $ | — | | Interest and other financing expense, net | $ | (212) | | | $ | — | | Cross-currency swaps | (1,124) | | | — | | Interest and other financing expense, net / Other expense (income), net | (1,120) | | | — | | Foreign currency forward contracts | (2) | | | 128 | | Cost of sales | 73 | | | 26 | | Total | $ | (785) | | | $ | 128 | | | $ | (1,259) | | | $ | 26 | |
|
Pre-Tax Effect of Derivative Financial Instruments Electing Cash Flow Hedge Accounting on Consolidated Statements of Operations |
The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the three months ended of March 31, 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships | | | | | Three Months Ended March 31, 2021 | | Three Months Ended March 31, 2020 | | | | | Cost of sales | | Interest and other financing expense, net | | Other expense/income, net | | Cost of sales | | Interest and other financing expense, net | | Other expense/income, net | The effects of cash flow hedging: | | | | | | | | | | | | | (Loss) gain on cash flow hedging relationships | | | | | | | | | | | | | | Interest rate swaps | | | | | | | | | | | | | | | Amount of (loss) reclassified from AOCL into expense | $ | — | | | $ | (82) | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | Cross-currency swaps | | | | | | | | | | | | | | | Amount of gain reclassified from AOCL into income | $ | — | | | $ | 39 | | | $ | 1,200 | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | Foreign currency forward contracts | | | | | | | | | | | | | | | Amount of gain reclassified from AOCL into income | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | |
The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the nine months ended of March 31, 2021 and 2020: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships | | | | | Nine Months Ended March 31, 2021 | | Nine Months Ended March 31, 2020 | | | | | Cost of sales | | Interest and other financing expense, net | | Other expense (income), net | | Cost of sales | | Interest and other financing expense, net | | Other expense (income), net | The effects of cash flow hedging: | | | | | | | | | | | | | (Loss) gain on cash flow hedging relationships | | | | | | | | | | | | | | Interest rate swaps | | | | | | | | | | | | | | | Amount of (loss) gain reclassified from AOCL into expense | $ | — | | | $ | (212) | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | Cross-currency swaps | | | | | | | | | | | | | | | Amount of gain (loss) reclassified from AOCL into income (expense) | $ | — | | | $ | 120 | | | $ | (1,240) | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | Foreign currency forward contracts | | | | | | | | | | | | | | | Amount of gain reclassified from AOCL into income | $ | 73 | | | $ | — | | | $ | — | | | $ | 26 | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | |
|
Pre-Tax Effect of Net Investment Hedges on Accumulated Other Comprehensive Loss and the Consolidated Statements of Operations |
The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | | | | | Derivatives in Net Investment Hedging Relationships | Amount of Gain (Loss) Recognized in OCI on Derivatives | Location of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing) | Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing) | | Three Months Ended March 31, | | Three Months Ended March 31, | | 2021 | | 2020 | | 2021 | | 2020 | Cross-currency swaps | $ | 3,933 | | | $ | — | | Interest and other financing expense, net | $ | 123 | | | $ | — | |
The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the nine months ended March 31, 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | | | | | Derivatives in Net Investment Hedging Relationships | Amount of Gain (Loss) Recognized in OCI on Derivatives | Location of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing) | Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing) | | Nine Months Ended March 31, | | Nine Months Ended March 31, | | 2021 | | 2020 | | 2021 | | 2020 | Cross-currency swaps | $ | (3,498) | | | $ | — | | Interest and other financing expense, net | $ | 377 | | | $ | — | |
Non-Designated Hedges
|
Pre-Tax Effect of Derivative Financial Instruments Not Designated as Hedging Instruments on the Consolidated Statements of Operations |
The following table presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the Consolidated Statements Operations for the three months ended March 31, 2021 and 2020: | | | | | | | | | | | | | | | Derivatives Not Designated as Hedging Instruments | Location of Gain (Loss) Recognized in Income on Derivative | Amount of Gain (Loss) Recognized in Income on Derivatives | | | Three Months Ended March 31, | | | 2021 | | 2020 | Foreign currency forward contracts | Other (income) expense, net | $ | — | | | $ | (336) | |
The following table presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the Consolidated Statements Operations for the nine months ended March 31, 2021 and 2020:
| | | | | | | | | | | | | | | Derivatives Not Designated as Hedging Instruments | Location of Gain (Loss) Recognized in Income on Derivative | Amount of Gain (Loss) Recognized in Income on Derivatives | | | Nine Months Ended March 31, | | | 2021 | | 2020 | Foreign currency forward contracts | Other (income) expense, net | $ | (399) | | | $ | (505) | |
|